Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use in Europe

EU Authorized Novavax's Vaccine

Most Accessed Articles: November 2021
Highlights from Chemistry Europe, ACES, and GDCh journals

Replacing Fossil-Based Electricity with Renewable Electricity
ENGIE and BASF sign power purchase agreement for renewable energy in Europe

Clariant Offers HNO3 Producers Free N2O-Removal Catalyst
Clariant wants to avoid greenhouse gas emissions amounting to several million tons of carbon dioxide

Expanding the Usage of RNAi Technology
Novo Nordisk to acquire Dicerna Pharmaceuticals

Seven Large-Scale Projects Funded by EU Innovation Fund
One of the world's largest funding programs for demonstrating innovative low-carbon technologies

Shell To Move Its Headquarters To The UK
This is part of a proposal to simplify the corporate structure, subject to shareholder approval

Dow Jones Sustainability Indices – Annual Review 2021
Global index tracking the stock performance of the world's leading companies in terms of sustainability

LGBT+ Business Leaders And Allies
The global OUTstanding LGBT+ Role Model Lists showcase people who are creating more inclusive workplaces across the world

Most Accessed Articles: October 2021
Highlights from Chemistry Europe, ACES, and GDCh journals